EQ-5D-3L DECREMENTS BY DIABETES COMPLICATIONS AND COMORBIDITIES IN CHINA

Y. Zhang,L. Shi,J. Wu,Y. Chen

DOI: https://doi.org/10.1016/j.jval.2018.04.547

IF: 5.156

2018-01-01

Value in Health

Abstract:To estimate the decrements on EQ-5D-3L scores by diabetes complications and comorbidities in type 2 diabetes patients with ongoing oral drug treatments in China. The secondary database study analyzed 9,570 type 2 diabetes patients with ongoing oral drugs treatment who were enrolled from 75 hospitals in 9 cities in China. Surveys were used to collect information including demographic data, health conditions, oral treatment history, and health insurance coverage situation. The EuroQol (EQ-5D-3L) scale was used to collect health utility and was scored by a Chinese version EQ-5D-3L conversion formula. Linear regression was used to analyze the associations between complications and health utility. Among 7,081 patients completed survey data, mean age was 59.6 (SD=12.64) years old, 3,479 (49.13%) patients were females, average duration of type 2 diabetes was 7.91 (SD=6.22) years. 5180 (73.28%) patients had at least one complication. The most common complication was hypertension (51.25%), followed by hyperlipidemia (28.90%). Other complications included cardiovascular disease, stroke, retinopathy, nephropathy, diabetic foot, and hypoglycemia. Average number of complications among participants was 1.54. Each complication had negative influence on the EQ-5D-3L score Among patients with complications, diabetic foot had the worst effect on EQ-5D-3L score (coefficient=-0.12, p=.000), followed by stroke (coefficient=-0.99, p=0.000) and nephropathy (coefficient=-0.06, p=0.000). The common complications and comorbidities among type 2 diabetes patients with ongoing oral drug treatments have significant decrements on health utility scores, especially for those with diabetic foot, stroke, and nephropathy.